Seth Harmon
Finanzdirektor/CFO bei VIRIDIAN THERAPEUTICS, INC.
Vermögen: 12 700 $ am 30.04.2024
Aktive Positionen von Seth Harmon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 12.09.2023 | - |
| Finanzdirektor/CFO | 12.09.2023 | - | |
| Corporate Officer/Principal | 01.05.2023 | 12.09.2023 |
Karriereverlauf von Seth Harmon
Ehemalige bekannte Positionen von Seth Harmon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIONTECH SE | Finanzdirektor/CFO | 01.05.2020 | 01.05.2023 |
| NEON THERAPEUTICS, INC. | Corporate Officer/Principal | 01.04.2017 | 01.05.2020 |
Ausbildung von Seth Harmon
| Northeastern University | Graduate Degree |
| Bowdoin College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Deutschland | 2 |
Operativ
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| BIONTECH SE | Health Technology |
| Private Unternehmen | 1 |
|---|---|
BioNTech US, Inc.
 BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Seth Harmon
- Erfahrung
